publication date: Sep. 21, 2018

In Brief Soria, Mok, Jänne, and Foti win ESMO 2018 awards

The European Society for Medical Oncology has announces four distinguished oncology professionals who will receive its annual awards during the ESMO 2018 Congress in Munich. The awardees are:

Jean-Charles SoriaJean-Charles Soria, an international lung cancer expert and pioneer in the development of anti-cancer drugs, will receive the ESMO Award. Soria has been involved in translational research related to precision medicine and tumour progression and has led multiple precision medicine trials.

Tony MokTony Mok will receive the ESMO Lifetime Achievement Award 2018 for his practice-changing contribution to lung cancer. He was principal investigator of the first study confirming the application of precision medicine in advanced lung cancer. He has also led and co-led multiple international phase III studies that have defined current management of advanced lung cancer.

Pasi JännePasi A. Jänne will receive the ESMO Translational Research Award 2018 for his contribution to changing the treatment paradigm of lung cancer. Jänne’s research combines laboratory-based studies with translational research and clinical trials of novel therapeutic agents in patients with lung cancer.

Margaret Foti Margaret Foti is the 2018 ESMO Women for Oncology Awardee in consideration of the legacy of young women, minority scientists, and investigators-in-training whose careers have been advanced as a result of her mentorship and support.

Continue reading Soria, Mok, Jänne, and Foti win ESMO 2018 awards

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.